Animal Health Company Collaboration

About Oblique Therapeutics

Oblique Therapeutics is a private, pre-revenue biotech leveraging its proprietary AbiProt® platform to generate novel antibody therapeutics against historically undruggable targets, primarily in pain and oncology. The company has validated its technology through strategic collaborations with major players like Eli Lilly and a leading animal health company. Led by an experienced team with a strong pharma background, Oblique aims to build a portfolio of assets while monetizing its platform through partnerships.

Therapeutic Areas